PDSB - PDS Biotechnology Corporation -  [ ]

Ticker Details
PDS Biotechnology Corporation
IPO Date: October 2, 2015
Sector: Healthcare
Industry: Biotech
Market Cap: $59.72M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.19 | 4.18%
Avg Daily Range (30 D): $0.04 | 5.93%
Avg Daily Range (90 D): $0.04 | 4.63%
Institutional Daily Volume
Avg Daily Volume: .57M
Avg Daily Volume (30 D): .48M
Avg Daily Volume (90 D): .51M
Trade Size
Avg Trade Size (Sh.): 184
Avg Trade Size (Sh.) (30 D): 321
Avg Trade Size (Sh.) (90 D): 323
Institutional Trades
Total Institutional Trades: 26
Avg Institutional Trade: $1.98M
Avg Institutional Trade (30 D): $1.59M
Avg Institutional Trade (90 D): $1.59M
Avg Institutional Trade Volume: .42M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.99M
Avg Closing Trade (30 D): $.72M
Avg Closing Trade (90 D): $.72M
Avg Closing Volume: 791.96K
 
News
Jan 12, 2026 @ 3:35 PM
Fast-Tracking the $537B Cancer Cure: How Accelerat...
Source: Prnewswire
Nov 11, 2025 @ 8:31 PM
PDS Biotechnology Announces up to $11.1 Million Re...
Source: Pds Biotechnology Corporation
Aug 13, 2025 @ 11:21 AM
PDSB Loss Improves as Costs Drop
Source: Jesterai
Dec 6, 2024 @ 1:00 PM
PDS Biotechnology Reports Inducement Grant Under N...
Source: N/A
Oct 2, 2024 @ 12:00 PM
PDS Biotech Announces 36-Month Overall Survival Ra...
Source: N/A
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-.74 $-.14 $-.74
Diluted EPS $-.74 $-.14 $-.74
Revenue $M $M $M
Gross Profit
Net Income / Loss $-34.5M $-7.56M $-34.5M
Operating Income / Loss $-31.54M $-6.67M $-31.54M
Cost of Revenue
Net Cash Flow $M $M $M
PE Ratio    
Splits
Mar 18, 2019 1:20